A look back at our first revenue-based investment (2020-2024)
In March 2020, we launched our very first revenue-based investment at Limitless, driven by a simple but ambitious goal: to close the funding gap for purpose-driven startups in Europe. We believed there had to be a better way to support entrepreneurs solving meaningful problems—one that didn’t require them to give up ownership to compromise on long-term impact for short-term gains.
Four years later, that investment has come full circle. Last June, we wrapped up our revenue-share agreement with Dermtest, The results are in—financially, the investment delivered as expected. But more importantly, it played a role in supporting healthcare when it was needed most.